CLINICAL_TRIALS
trial_result
· 2013-02-20
Clinical Trial Update: A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris [Phase 1]
Summary
The Phase 1 study of JNJ 10229570-AAA completed in Japanese participants with acne vulgaris to evaluate safety and tolerability.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED